Literature DB >> 2659202

C-reactive protein: the best laboratory indicator available for monitoring disease activity.

S D Deodhar.   

Abstract

Recent technical advances in measurement of serum C-reactive protein (CRP) have made this laboratory test highly specific, sensitive, reproducible, quantitative, and easy and rapid to perform. Several studies have shown that serial and quantitative measurement of serum CRP can be very helpful in monitoring disease activity in a wide variety of clinical situations, and that CRP testing offers distinct advantages over testing for any of the other acute-phase reactants. CRP testing is superior to erythrocyte sedimentation rate (ESR) measurements on clinical, scientific, and practical grounds, and it is strongly recommended that serious consideration be given to replacing ESR with CRP testing for monitoring disease activity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2659202     DOI: 10.3949/ccjm.56.2.126

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  18 in total

1.  High-sensitive factor I and C-reactive protein based biomarkers for coronary artery disease.

Authors:  Qing Zhao; Jian-Shi Du; Dong-Mei Han; Ying Ma
Journal:  Int J Clin Exp Med       Date:  2014-12-15

2.  Pre-operative serum C-reactive protein as independent prognostic factor for survival but not infection in patients with high-grade osteosarcoma.

Authors:  Philipp T Funovics; Gundula Edelhauser; Martin A Funovics; Christoph Laux; Dominik Berzaczy; Bernd Kubista; Rainer I Kotz; Martin Dominkus
Journal:  Int Orthop       Date:  2011-01-21       Impact factor: 3.075

3.  GWAS-Supported CRP Gene Polymorphisms and Functional Outcome of Large Artery Atherosclerotic Stroke in Han Chinese.

Authors:  Zusen Ye; Hao Zhang; Lingli Sun; Huan Cai; Yonggang Hao; Zongliang Xu; Zhizhong Zhang; Xinfeng Liu
Journal:  Neuromolecular Med       Date:  2018-03-19       Impact factor: 3.843

4.  Serum C-reactive protein as an important prognostic variable in patients with diffuse large B cell lymphoma.

Authors:  Ye Cao; Yan-xia Shi; Jing-ou Chen; Yu-ting Tan; Yu-Chen Cai; Hui-yan Luo; Miao-zhen Qiu; Xiu-yu Cai; Ying Jin; Yue-li Sun; Wen-qi Jiang
Journal:  Tumour Biol       Date:  2012-02-11

5.  Elevated Tenascin-C Serum Levels in Patients With Axial Spondyloarthritis.

Authors:  K Bubová; K Prajzlerová; H Hulejová; M Gregová; K Mintálová; M Hušáková; Š Forejtová; M Filková; M Tomčík; J Vencovský; K Pavelka; L Šenolt
Journal:  Physiol Res       Date:  2020-06-25       Impact factor: 1.881

6.  Evaluation of the Variations in the Levels of Perioperative Inflammatory Markers After Open Reduction and Internal Fixation of Maxillofacial Fractures.

Authors:  Parveen Sharma; Rishi Kumar Bali; Avneet Kaur; Shivani Gaba; Guneet Dhillon
Journal:  J Maxillofac Oral Surg       Date:  2018-11-20

Review 7.  Inflammatory Biomarkers in the Short-Term Prognosis of Venous Thromboembolism: A Narrative Review.

Authors:  Francisco Galeano-Valle; Lucía Ordieres-Ortega; Crhistian Mario Oblitas; Jorge Del-Toro-Cervera; Luis Alvarez-Sala-Walther; Pablo Demelo-Rodríguez
Journal:  Int J Mol Sci       Date:  2021-03-05       Impact factor: 5.923

Review 8.  Bench-to-bedside review: the value of cardiac biomarkers in the intensive care patient.

Authors:  Anthony S McLean; Stephen J Huang; Mark Salter
Journal:  Crit Care       Date:  2008-06-02       Impact factor: 9.097

9.  C-reactive protein is a predictor of complications after elective laparoscopic colorectal surgery: five-year experience.

Authors:  Eligijus Poskus; Ignas Karnusevicius; Gintare Andreikaite; Saulius Mikalauskas; Tomas Poskus; Kestutis Strupas
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2015-09-14       Impact factor: 1.195

Review 10.  C-reactive protein as a prognostic factor for human osteosarcoma: a meta-analysis and literature review.

Authors:  Jian-Hua Yi; Dong Wang; Zhi-Yong Li; Jun Hu; Xiao-Feng Niu; Xiao-Lin Liu
Journal:  PLoS One       Date:  2014-05-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.